Infections Caused by Resistant Gram-Negative Bacteria: Epidemiology and Management
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Infections Caused by Resistant Gram-Negative Bacteria: Epidemiology and Management
Authors
Keywords
-
Journal
PHARMACOTHERAPY
Volume 35, Issue 10, Pages 949-962
Publisher
Wiley
Online
2015-10-25
DOI
10.1002/phar.1636
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ceftolozane/Tazobactam Therapy of Respiratory Infections due to Multidrug-ResistantPseudomonas aeruginosa: Table 1.
- (2015) Michael S. Gelfand et al. CLINICAL INFECTIOUS DISEASES
- Incidence and Risk Factors for Colistin-Associated Nephrotoxicity
- (2015) Fatih Temocin et al. JAPANESE JOURNAL OF INFECTIOUS DISEASES
- Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI)
- (2015) Florian M Wagenlehner et al. LANCET
- Preliminary Study of Colistin versus Colistin plus Fosfomycin for Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections
- (2014) Rujipas Sirijatuphat et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems
- (2014) George L. Daikos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Extended-Infusion Cefepime Reduces Mortality in Patients with Pseudomonas aeruginosa Infections
- (2013) Karri A. Bauer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Activity of Ceftolozane-Tazobactam Tested against Enterobacteriaceae and Pseudomonas aeruginosa with Various Resistance Patterns Isolated in U.S. Hospitals (2011-2012)
- (2013) David J. Farrell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacological Basis of β-Lactamase Inhibitor Therapeutics: Tazobactam in Combination with Ceftolozane
- (2013) Brian VanScoy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Structural Insight into Potent Broad-Spectrum Inhibition with Reversible Recyclization Mechanism: Avibactam in Complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-Lactamases
- (2013) Sushmita D. Lahiri et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenem-resistant Enterobacteriaceae: A menace to our most vulnerable patients
- (2013) F. Perez et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
- (2013) Emanuele Durante-Mangoni et al. CLINICAL INFECTIOUS DISEASES
- ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients
- (2013) E. Tacconelli et al. CLINICAL MICROBIOLOGY AND INFECTION
- Antimicrobial Susceptibility of Inpatient Urinary Tract Isolates of Gram-Negative Bacilli in the United States: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program: 2009−2011
- (2013) Sam K. Bouchillon et al. CLINICAL THERAPEUTICS
- Trends in susceptibility of selected gram-negative bacilli isolated from intra-abdominal infections in North America: SMART 2005–2010
- (2013) Tim Babinchak et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes
- (2013) David van Duin et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination
- (2013) George G. Zhanel et al. DRUGS
- Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli
- (2013) George G. Zhanel et al. DRUGS
- Carbapenem-resistantAcinetobacter baumannii: epidemiology, surveillance and management
- (2013) Jason M Pogue et al. Expert Review of Anti-Infective Therapy
- Automated Alerts Coupled with Antimicrobial Stewardship Intervention Lead to Decreases in Length of Stay in Patients with Gram-Negative Bacteremia
- (2013) Jason M. Pogue et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Risk factors for carbapenem-resistant Gram-negative bacteremia in intensive care unit patients
- (2013) Christina Routsi et al. INTENSIVE CARE MEDICINE
- Monitoring the global in vitro activity of ertapenem against Escherichia coli from intra-abdominal infections: SMART 2002–2010
- (2013) Stephen P. Hawser et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Determining a clinical framework for use of cefepime and -lactam/ -lactamase inhibitors in the treatment of infections caused by extended-spectrum- -lactamase-producing Enterobacteriaceae
- (2013) H. M. Nguyen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial
- (2013) Christopher Lucasti et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antimicrobial susceptibility among gram-negative isolates collected in the USA between 2005 and 2011 as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.)
- (2013) Gerald A Denys et al. Annals of Clinical Microbiology and Antimicrobials
- The burden of multidrug-resistant organisms on tertiary hospitals posed by patients with recent stays in long-term acute care facilities
- (2012) Dror Marchaim et al. AMERICAN JOURNAL OF INFECTION CONTROL
- In VivoActivities of Ceftolozane, a New Cephalosporin, with and without Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae, Including Strains with Extended-Spectrum β-Lactamases, in the Thighs of Neutropenic Mice
- (2012) W. A. Craig et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Increased multi-drug resistance among the elderly on admission to the hospital—A 12-year surveillance study
- (2012) Claudia M. Denkinger et al. ARCHIVES OF GERONTOLOGY AND GERIATRICS
- Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
- (2012) M. Tumbarello et al. CLINICAL INFECTIOUS DISEASES
- High-Dose, Extended-Interval Colistin Administration in Critically Ill Patients: Is This the Right Dosing Strategy? A Preliminary Study
- (2012) L. Dalfino et al. CLINICAL INFECTIOUS DISEASES
- Community-Associated Extended-Spectrum β-Lactamase–Producing Escherichia coli Infection in the United States
- (2012) Yohei Doi et al. CLINICAL INFECTIOUS DISEASES
- Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
- (2012) P. D. Tamma et al. CLINICAL MICROBIOLOGY REVIEWS
- Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions
- (2012) L. S. Tzouvelekis et al. CLINICAL MICROBIOLOGY REVIEWS
- Efficacy and safety of ceftazidime–avibactam versus imipenem–cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study
- (2012) José A. Vazquez et al. CURRENT MEDICAL RESEARCH AND OPINION
- Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010
- (2012) Dawn M. Sievert et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum -lactamases: a systematic review and meta-analysis
- (2012) K. Z. Vardakas et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Intrapulmonary penetration of ceftolozane/tazobactam and piperacillin/tazobactam in healthy adult subjects
- (2012) G. Chandorkar et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- OXA-48-like carbapenemases: the phantom menace
- (2012) L. Poirel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Tracking a Hospital Outbreak of Carbapenem-Resistant Klebsiella pneumoniae with Whole-Genome Sequencing
- (2012) E. S. Snitkin et al. Science Translational Medicine
- Trends in antimicrobial resistance in intensive care units in the United States
- (2011) Kavitha Prabaker et al. Current Opinion in Critical Care
- In vitro activity of CXA-101 plus tazobactam (CXA-201) against CTX-M-14– and CTX-M-15–producing Escherichia coli and Klebsiella pneumoniae
- (2011) Emilia Titelman et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Patterns of Ciprofloxacin-Resistant Gram-Negative Bacteria Colonization in Nursing Home Residents
- (2011) Parimala Dommeti et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae
- (2011) Z. Aktaş et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Current Concepts in Antimicrobial Therapy Against Resistant Gram-Negative Organisms: Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae, Carbapenem-Resistant Enterobacteriaceae, and Multidrug-Resistant Pseudomonas aeruginosa
- (2011) Souha S. Kanj et al. MAYO CLINIC PROCEEDINGS
- Recognition and prevention of multidrug-resistant Gram-negative bacteria in the intensive care unit
- (2010) Lisa L. Maragakis CRITICAL CARE MEDICINE
- Treatment ofAcinetobacterinfections
- (2010) Argyris Michalopoulos et al. EXPERT OPINION ON PHARMACOTHERAPY
- Current Epidemiology of Multidrug-Resistant Gram-Negative Bacilli in the United States
- (2010) Alexander J. Kallen et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii
- (2010) Wang-Huei Sheng et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens
- (2010) Yvonne Pfeifer et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Extracellular concentrations of fosfomycin in lung tissue of septic patients
- (2010) V. Matzi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of a New Antipseudomonal Cephalosporin, CXA-101 (FR264205), against Carbapenem-Resistant and Multidrug-Resistant Pseudomonas aeruginosa Clinical Strains
- (2009) C. Juan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Attributable Hospital Cost and Length of Stay Associated with Health Care-Associated Infections Caused by Antibiotic-Resistant Gram-Negative Bacteria
- (2009) P. D. Mauldin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Diversity, Epidemiology, and Genetics of Class D -Lactamases
- (2009) L. Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bad Bugs, No Drugs: No ESCAPE Revisited
- (2009) Lance R. Peterson CLINICAL INFECTIOUS DISEASES
- Multidrug-resistantPseudomonas aeruginosaandAcinetobacter baumannii: resistance mechanisms and implications for therapy
- (2009) Alexandre P Zavascki et al. Expert Review of Anti-Infective Therapy
- Influx of Multidrug-Resistant, Gram-Negative Bacteria in the Hospital Setting and the Role of Elderly Patients With Bacterial Bloodstream Infection
- (2009) Aurora Pop-Vicas et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
- (2009) Jean-Louis Vincent JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection
- (2009) M. V. Schintler et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Extended-spectrum β-lactamase-producing organisms
- (2009) M.E. Falagas et al. JOURNAL OF HOSPITAL INFECTION
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Clinical and economic burden of antimicrobial resistance
- (2008) Lisa L Maragakis et al. Expert Review of Anti-Infective Therapy
- Treatment of Recurrent Urosepsis with Tigecycline: a Pharmacological Perspective
- (2008) D. Curcio JOURNAL OF CLINICAL MICROBIOLOGY
- Multidrug-Resistant Gram-Negative Bacteria in a Long-Term Care Facility: Prevalence and Risk Factors
- (2008) Aurora Pop-Vicas et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
- (2008) Johann DD Pitout et al. LANCET INFECTIOUS DISEASES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started